Moderna, Inc. logo

Moderna, Inc.

NASDAQ:MRNA

Overview | Financials
Company Name Moderna, Inc.
Symbol MRNA
Currency USD
Price 68.02
Market Cap 26,146,615,920
Dividend Yield 0%
52-week-range 62.55 - 170.47
Industry Biotechnology
Sector Healthcare
CEO Mr. Stephane Bancel
Website https://www.modernatx.com

An error occurred while fetching data.

About Moderna, Inc.

Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, respiratory syncytial virus, Endemic HCoV, and hMPV+PIV3 vaccines; latent

Related Stocks

Illumina, Inc. logo

Illumina, Inc.

ILMN

134.39 USD

Walgreens Boots Alliance, Inc. logo

Walgreens Boots Alliance, Inc.

WBA

8.98 USD

Vertex Pharmaceuticals Incorporated logo

Vertex Pharmaceuticals Incorporated

VRTX

477.9 USD

IDEXX Laboratories, Inc. logo

IDEXX Laboratories, Inc.

IDXX

517.06 USD

Biogen Inc. logo

Biogen Inc.

BIIB

201.44 USD

DexCom, Inc. logo

DexCom, Inc.

DXCM

71.92 USD

Royalty Pharma plc logo

Royalty Pharma plc

RPRX

27.99 USD

Financials

Numbers are in millions USD

Numbers are in millions USD